Ident. | Authors (with country if any) | Title |
---|
000151 (2017) |
Anjali Modi [Inde] ; Sukesha Gamit [Inde] ; Bharat S. Jesalpura [Inde] ; George Kurien [Inde] ; Jayendra K. Kosambiya [Inde] | Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India. |
000304 (2017) |
Chet Raj Ojha [États-Unis] ; Basant Joshi [Népal] ; Khagendra Prakash Kc [Népal] ; Shyam Prakash Dumre [Japon] ; Keshav Kumar Yogi [Népal] ; Bandana Bhatta [Népal] ; Tulasi Adhikari [Népal] ; Kathryn Crowley [États-Unis] ; Babu Ram Marasini [Népal] | Impact of mass drug administration for elimination of lymphatic filariasis in Nepal. |
000340 (2017) |
Hugues C. Nana-Djeunga [Cameroun] ; Magellan Tchouakui [Cameroun] ; Guy R. Njitchouang [Cameroun] ; Jules B. Tchatchueng-Mbougua [Cameroun] ; Philippe Nwane [Cameroun] ; André Domche [Cameroun] ; Jean Bopda [Cameroun] ; Stève Mbickmen-Tchana [Cameroun] ; Julie Akame [Cameroun] ; Ann Tarini [Cameroun] ; Emilienne Epée [Cameroun] ; Benjamin D. Biholong [Cameroun] ; Yaobi Zhang [Sénégal] ; Jean J. Tougoue [États-Unis] ; Achille Kabore [États-Unis] ; Flobert Njiokou [Cameroun] ; Joseph Kamgno [Cameroun] | First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination. |
000374 (2017) |
Sébastien D S. Pion [France] ; Cédric B. Chesnais [France] ; Gary J. Weil [États-Unis] ; Peter U. Fischer [États-Unis] ; François Missamou [République du Congo] ; Michel Boussinesq [République du Congo] | Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in Republic of the Congo. |
000479 (2017) |
Dziedzom Komi De Souza [Ghana] ; Irene Offei Owusu [Ghana] ; Joseph Otchere [Ghana] ; Michelle Adimazoya [Ghana] ; Kwadwo Frempong [Ghana] ; Collins Stephen Ahorlu [Ghana] ; Daniel Adjei Boakye [Ghana] ; Michael David Wilson [Ghana] | An evaluation of Wb123 antibody elisa in individuals treated with ivermectin and albendazole, and implementation challenges in Africa. |
000615 (2016) |
Denise Mupfasoni [Suisse] ; Antonio Montresor [Suisse] ; Alexei Mikhailov [Suisse] ; Jonathan King [Suisse] | The Impact of Lymphatic Filariasis Mass Drug Administration Scaling Down on Soil-Transmitted Helminth Control in School-Age Children. Present Situation and Expected Impact from 2016 to 2020. |
000707 (2016) |
Inge Kroidl [Allemagne] ; Elmar Saathof [Allemagne] ; Lucas Maganga [Tanzanie] ; Petra Clowes [Allemagne] ; Leonard Maboko [Tanzanie] ; Achim Hoerauf [Allemagne] ; Williams H. Makunde [Tanzanie] ; Antelmo Haule [Tanzanie] ; Prisca Mviombo [Tanzanie] ; Bettina Pitter [Allemagne] ; Neema Mgeni [Tanzanie] ; Joseph Mabuye [Tanzanie] ; Dickens Kowuor [Tanzanie] ; Upendo Mwingira [Tanzanie] ; Mwelecele N. Malecela [Tanzanie] ; Thomas Löscher [Allemagne] ; Michael Hoelscher [Allemagne] | Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania. |
000870 (2016) |
Alison Krentel [Royaume-Uni] ; Rita Damayanti [Indonésie] ; Christiana Rialine Titaley [Indonésie] ; Nugroho Suharno [Indonésie] ; Mark Bradley [Royaume-Uni] ; Timothy Lynam [Australie] | Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys. |
000926 (2016) |
Edward K. Thomsen [Papouasie-Nouvelle-Guinée] ; Nelly Sanuku [Papouasie-Nouvelle-Guinée] ; Manasseh Baea [Papouasie-Nouvelle-Guinée] ; Samson Satofan [Papouasie-Nouvelle-Guinée] ; Elit Maki [Papouasie-Nouvelle-Guinée] ; Bart Lombore [Papouasie-Nouvelle-Guinée] ; Mark S. Schmidt [États-Unis] ; Peter M. Siba [Papouasie-Nouvelle-Guinée] ; Gary J. Weil [États-Unis] ; James W. Kazura [États-Unis] ; Lawrence L. Fleckenstein [États-Unis] ; Christopher L. King [États-Unis] | Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis. |
000978 (2016) |
Jean Frantz Lemoine [Haïti] ; Anne Marie Desormeaux [Haïti] ; Franck Monestime [Haïti] ; Carl Renad Fayette [Haïti] ; Luccene Desir [Haïti] ; Abdel Nasser Direny [États-Unis] ; Sarah Carciunoiu [États-Unis] ; Lior Miller [États-Unis] ; Alaine Knipes [États-Unis] ; Patrick Lammie [États-Unis] ; Penelope Smith [États-Unis] ; Melissa Stockton [États-Unis] ; Lily Trofimovich [États-Unis] ; Kalpana Bhandari [États-Unis] ; Richard Reithinger [États-Unis] ; Kathryn Crowley [États-Unis] ; Eric Ottesen [États-Unis] ; Margaret Baker [États-Unis] | Controlling Neglected Tropical Diseases (NTDs) in Haiti: Implementation Strategies and Evidence of Their Success. |
000A22 (2016) |
I P Sunish [Inde] ; M. Kalimuthu [Inde] ; V Ashok Kumar [Inde] ; A. Munirathinam [Inde] ; J. Nagaraj [Inde] ; B K Tyagi [Inde] ; Graham B. White [États-Unis] ; N. Arunachalam [Inde] | Can community-based integrated vector control hasten the process of LF elimination? |
000A94 (2016) |
Philip J. Budge [États-Unis] ; Edmond Sognikin [Togo] ; Amanda Akosa [États-Unis] ; Els M. Mathieu [États-Unis] ; Michael Deming [États-Unis] | Accuracy of Coverage Survey Recall following an Integrated Mass Drug Administration for Lymphatic Filariasis, Schistosomiasis, and Soil-Transmitted Helminthiasis. |
000B51 (2015) |
A M Dorkenoo [France] ; Y K Sodahlon ; R N Bronzan ; K. Yakpa ; E. Sossou ; A. Ouro-Medeli ; M. Teko ; A. Seim ; E. Mathieu | [Lymphatic filariasis transmission assessment survey in schools three years after stopping mass drug treatment with albendazole and ivermectin in the 7 endemic districts in Togo]. |
000C06 (2015) |
Fred Aboagye-Antwi [Ghana] ; Bethel Kwansa-Bentum [Ghana] ; Samuel K. Dadzie [Ghana] ; Collins K. Ahorlu [Ghana] ; Maxwell A. Appawu [Ghana] ; John Gyapong [Ghana] ; Michael David Wilson [Ghana] ; Daniel Adjei Boakye [Ghana] | Transmission indices and microfilariae prevalence in human population prior to mass drug administration with ivermectin and albendazole in the Gomoa District of Ghana. |
000C22 (2015) |
Sébastien D S. Pion [France] ; Cédric B. Chesnais [États-Unis] ; Jean Bopda [États-Unis] ; Frédéric Louya [États-Unis] ; Peter U. Fischer [États-Unis] ; Andrew C. Majewski [États-Unis] ; Gary J. Weil [États-Unis] ; Michel Boussinesq [États-Unis] ; François Missamou [États-Unis] | The impact of two semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in the Republic of Congo. |
000C38 (2015) |
Yaya I. Coulibaly [France] ; Benoit Dembele [Suisse] ; Abdallah Amadou Diallo [Suisse] ; Siaka Konaté [Suisse] ; Houseini Dolo [Suisse] ; Siaka Yamoussa Coulibaly [Suisse] ; Salif Seriba Doumbia [Suisse] ; Lamine Soumaoro [Suisse] ; Michel Emmanuel Coulibaly [Suisse] ; Moses J. Bockarie [Suisse] ; David Molyneux [Suisse] ; Thomas B. Nutman [Suisse] ; Amy D. Klion [Suisse] ; Yeya T. Toure [Suisse] ; Sekou F. Traore [Suisse] | The Impact of Six Annual Rounds of Mass Drug Administration on Wuchereria bancrofti Infections in Humans and in Mosquitoes in Mali. |
000D03 (2015) |
M. Kalimuthu [Inde] ; I P Sunish ; J. Nagaraj ; A. Munirathinam ; V Ashok Kumar ; N. Arunachalam ; G B White ; B K Tyagi | Residual microfilaraemia in rural pockets of South India after five rounds of DEC plus albendazole administration as part of the LF elimination campaign. |
000D05 (2015) |
Christina A. Bulman [États-Unis] ; Chelsea M. Bidlow [États-Unis] ; Sara Lustigman [États-Unis] ; Fidelis Cho-Ngwa [Cameroun] ; David Williams [États-Unis] ; Alberto A. Rasc N [États-Unis] ; Nancy Tricoche [États-Unis] ; Moses Samje [Cameroun] ; Aaron Bell [États-Unis] ; Brian Suzuki [États-Unis] ; K C Lim [États-Unis] ; Nonglak Supakorndej [États-Unis] ; Prasit Supakorndej [États-Unis] ; Alan R. Wolfe [États-Unis] ; Giselle M. Knudsen [États-Unis] ; Steven Chen [États-Unis] ; Chris Wilson [États-Unis] ; Kean-Hooi Ang [États-Unis] ; Michelle Arkin [États-Unis] ; Jiri Gut [États-Unis] ; Chris Franklin [États-Unis] ; Chris Marcellino [États-Unis] ; James H. Mckerrow [États-Unis] ; Anjan Debnath [États-Unis] ; Judy A. Sakanari [États-Unis] | Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis. |
000D37 (2015) |
Gregory S. Noland ; Stephen Blount [République dominicaine] ; Manuel Gonzalez [République dominicaine] | Post-Mass Drug Administration Transmission Assessment Survey for Elimination of Lymphatic Filariasis in La Ciénaga, Dominican Republic. |
000D51 (2015) |
Darin S. Evans [États-Unis] ; Thomas R. Unnasch [États-Unis] ; Frank O. Richards [États-Unis] | Onchocerciasis and lymphatic filariasis elimination in Africa: it's about time. |
000E70 (2015) |
I P Sunish ; R. Rajendran ; A. Munirathinam ; M. Kalimuthu ; V Ashok Kumar ; J. Nagaraj ; B K Tyagi [Inde] | Impact on prevalence of intestinal helminth infection in school children administered with seven annual rounds of diethyl carbamazine (DEC) with albendazole. |